Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF

Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF

Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF

Learn about emerging data from the AFFIRM-AHF trial in patients hospitalized with heart failure who undergo treatment with intravenous iron therapy.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Do you know that as many as 70% of patients hospitalized with heart failure are iron deficient? This condition is associated with reduced functional capacity, reduced quality of life, and adverse outcomes. Come and explore the new data from the AFFIRM-AHF trial on repletion of iron deficiency in this population and discover the effect of iron on hospitalization rates. What practical steps should you be taking to improve the health of your patients with heart failure?  

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Gregory Lewis, MD
    Medical Director, Cardiac Transplantation Program
    Director, Cardiopulmonary Exercise Laboratory
    Massachusetts General Hospital
    Boston, MA 

    Royalties: Up-To-Date
    Consulting Fees: Boerhinger-Ingelheim, Pfizer
    Contracted Research: Amgen, Cytokinetics

    Michael Böhm, MD, FESC
    Professor of Internal Medicine and Cardiology and Director of Internal Medicine
    Saarland University
    Homburg/Saar, Germany 

    Consulting Fees: Amgen, Novartis, Servier, Vifor Pharma

    Josep Comin-Colet, MD, PhD
    Director, Cardiology Department
    University of Barcelona
    Barcelona, Spain 

    Consulting Fees: Vifor Pharma

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Ben Caref, PhD, has nothing to disclose.
    • Megan Clem has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Stephanie Wenick has nothing to disclose.
  • Learning Objective

    After participating in this educational activity, participants should be better able to:

    • Translate key findings from emerging data on the management of iron deficiency in acute decompensated heart failure into clinical practice.
  • Target Audience

    This activity is designed to meet the educational needs of heart failure specialists, cardiologists, primary care physicians, nephrologists, and all other allied healthcare professionals involved in the diagnosis, treatment, and care of heart failure.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.

  • Commercial Support

    This activity is supported by an independent educational grant from Vifor Pharma.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free